• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

355
65
48
46
18

COUNTRY

45
12
5
5
5

PRICE

291
546
1,137
1,426

PUBLISHED

68
112
496
1,426

PRODUCT TYPE

1,329
67
17
13

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE
Zispin-Drug Insights,2014 Zispin-Drug Insights,2014 - Product Thumbnail Image

Zispin-Drug Insights,2014

“Zispin - Drug Insights, 2014” provides Zispin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

February 2015
FROM
Lamictal-Drug Insights,2014 Lamictal-Drug Insights,2014 - Product Thumbnail Image

Lamictal-Drug Insights,2014

“Lamictal XR - Drug Insights, 2014” provides Lamictal XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Trioptal-Drug Insights,2014 Trioptal-Drug Insights,2014 - Product Thumbnail Image

Trioptal-Drug Insights,2014

“Trioptal - Drug Insights, 2014” provides Trioptal marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Intuniv-Drug Insights,2014 Intuniv-Drug Insights,2014 - Product Thumbnail Image

Intuniv-Drug Insights,2014

“Intuniv XR - Drug Insights, 2014” provides Intuniv XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Diprivan EML-Drug Insights,2014 Diprivan EML-Drug Insights,2014 - Product Thumbnail Image

Diprivan EML-Drug Insights,2014

“Diprivan EML - Drug Insights, 2014” provides Diprivan EML marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US,...

February 2015
FROM
Opana ER-Drug Insights,2014 Opana ER-Drug Insights,2014 - Product Thumbnail Image

Opana ER-Drug Insights,2014

“Opana ER - Drug Insights, 2014” provides Opana ER marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Imitrex-Drug Insights,2014 Imitrex-Drug Insights,2014 - Product Thumbnail Image

Imitrex-Drug Insights,2014

“Imitrex - Drug Insights, 2014” provides Imitrex marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Dysport-Drug Insights,2014 Dysport-Drug Insights,2014 - Product Thumbnail Image

Dysport-Drug Insights,2014

“Dysport - Drug Insights, 2014” provides Dysport marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM

Global Anxiety Disorders Market 2015-2019

About Anxiety Disorders Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response....

January 2015
FROM

Acute Spinal Cord Injury - Pipeline Review, H2 2014

Acute Spinal Cord Injury - Pipeline Review, H2 2014 Summary This, ‘Acute Spinal Cord Injury - Pipeline Review, H2 2014’, provides an overview of the Acute Spinal Cord Injury’s therapeutic pipeline. This...

December 2014
FROM

Muscle Spasticity - Pipeline Review, H2 2014

Muscle Spasticity - Pipeline Review, H2 2014 Summary This, ‘Muscle Spasticity - Pipeline Review, H2 2014’, provides an overview of the Muscle Spasticity’s therapeutic pipeline. This report provides...

December 2014
FROM
Paralysis - Pipeline Review, H2 2014 Paralysis - Pipeline Review, H2 2014 - Product Thumbnail Image

Paralysis - Pipeline Review, H2 2014

Paralysis - Pipeline Review, H2 2014 Summary This, ‘Paralysis - Pipeline Review, H2 2014’, provides an overview of the Paralysis’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Trigeminal Neuralgia - Pipeline Review, H2 2014

Trigeminal Neuralgia - Pipeline Review, H2 2014 Summary This, ‘Trigeminal Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline. This report...

December 2014
FROM

Eastern Equine Encephalitis - Pipeline Review, H2 2014

Eastern Equine Encephalitis - Pipeline Review, H2 2014 Summary This, ‘Eastern Equine Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Eastern Equine Encephalitis’s therapeutic...

December 2014
FROM

Western Equine Encephalitis - Pipeline Review, H2 2014

Western Equine Encephalitis - Pipeline Review, H2 2014 Summary This, ‘Western Equine Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Western Equine Encephalitis’s therapeutic...

December 2014
FROM

Lennox-Gastaut Syndrome - Pipeline Review, H2 2014

Lennox-Gastaut Syndrome - Pipeline Review, H2 2014 Summary This, ‘Lennox-Gastaut Syndrome - Pipeline Review, H2 2014’, provides an overview of the Lennox-Gastaut Syndrome’s therapeutic pipeline. This...

December 2014
FROM
Leukodystrophies - Pipeline Review, H2 2014 Leukodystrophies - Pipeline Review, H2 2014 - Product Thumbnail Image

Leukodystrophies - Pipeline Review, H2 2014

Leukodystrophies - Pipeline Review, H2 2014 Summary This, ‘Leukodystrophies - Pipeline Review, H2 2014’, provides an overview of the Leukodystrophies’s therapeutic pipeline. This report provides...

December 2014
FROM
Age Related Memory Impairment - Pipeline Review, H2 2014 Age Related Memory Impairment - Pipeline Review, H2 2014 - Product Thumbnail Image

Age Related Memory Impairment - Pipeline Review, H2 2014

Age Related Memory Impairment - Pipeline Review, H2 2014 Summary This, ‘Age Related Memory Impairment - Pipeline Review, H2 2014’, provides an overview of the Age Related Memory Impairment’s therapeutic...

December 2014
FROM

Tardive Dyskinesia - Pipeline Review, H2 2014

Tardive Dyskinesia - Pipeline Review, H2 2014 Summary This, ‘Tardive Dyskinesia - Pipeline Review, H2 2014’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline. This report provides...

December 2014
FROM

Nerve Injury - Pipeline Review, H2 2014

Nerve Injury - Pipeline Review, H2 2014 Summary This, ‘Nerve Injury - Pipeline Review, H2 2014’, provides an overview of the Nerve Injury’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.